Search reports.
Pediatric Clinical Trials Market Size, Share, Growth | Forecast 2031
Get free sample report Request for Customiztion Buy Now

Pediatric Clinical Trials Market Size, Share, Growth | Forecast 2031

Segments - Pediatric Clinical Trials Market by Phases (Phase IV, Phase III, Phase I, and Phase II), Study Designs (Observational Studies, Treatment Studies, and Others), Therapeutic Areas (Diabetes, Respiratory Diseases, Oncology, Infectious Diseases, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa)– Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 - 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-2218 | 4.9 Rating | 70 Reviews | 175 Pages | Format : PDF Excel PPT

Report Description


Pediatric Clinical Trials Market Outlook 2031: 

The global pediatric clinical trials market size was valued at USD 15.24 Billion in 2022 and is projected to reach USD 23.85 Billion by 2031, expanding at a CAGR of 5.1% during the forecast period 2023 - 2031. Growth of the market is attributed to rapid urbanization, increasing number of clinical trials for covid-19, and increasing awareness about pediatric medicines.

Clinical trials typically test for identification of procedure & medicine which is suitable specific diseases. The test that is conducted on patient is in form of procedures, drug, and medical. During the pediatric clinical trial, the research protocol is followed by professional which is established by investigator.

Pediatric Clinical Trials Market Outlook

The Covid-19 pandemic affected the demand and supply of pediatric clinical trials market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

  • Increasing burden of pediatric diseases such as diabetes is projected to boost the market.
  • Rising importance of clinical research trials is the major factor fueling the pediatric clinical trials market growth.
  • High termination rate of clinical trials is projected to restrict the market expansion during the forecast period.
  • High price of services is anticipated to hamper the pediatric clinical trials market growth in the coming years.
  • R&D investment and technological advancement in pediatric clinical trials market is projected to offer lucrative opportunities for the market players.

Scope of Pediatric Clinical Trials Market Report

The report on the pediatric clinical trials market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Pediatric Clinical Trials Market– Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016 - 2021

Forecast Period

2023 - 2031

Segmentation

Phases (Phase IV, Phase III, Phase I, and Phase II), Study Designs (Observational Studies, Treatment Studies, and Others), Therapeutic Areas (Diabetes, Respiratory Diseases, Oncology, Infectious Diseases, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players covered in the Report

The Emmes Company, LLC; Syneos Health Inc.; Pfizer, Inc.; IQVIA; GlaxoSmithKline plc; Charles River Laboratories International Inc.; ICON plc; Bristol-Myers Squibb Company; Covance Inc.; Novartis AG; Pharmaceutical Product Development, LLC; and Paidion Research Inc.

Pediatric Clinical Trials Market Segment Insights

The oncology segment accounts for key share of the market

Based on therapeutic areas, the pediatric clinical trials market is fragmented into diabetes, respiratory diseases, oncology, infectious diseases, and others. The oncology segment accounts for a key share of the market. Growth of the market is attributed to rapid development in pediatric trials and increasing technological advancement in hospital sector.

However, the diabetes segment is anticipated to expand at a rapid pace during the forecast period due to rapid expansion in development & research, wide range of applications in respiratory diseases, and increasing per capita income.

The treatment studies segment is anticipated to hold significant market share

On the basis of study designs, the pediatric clinical trials market share is divided into observational studies, treatment studies, and others. The treatment studies segment accounts for a significant share of the market. Growth of the market is attributed to rapid shift in pharmaceutical industry from in house clinical research to contract research organization.

The observational studies are anticipated to expand at a rapid pace during forecast period due to factors such as rapidly growing pharmaceutical industry, rising investment by government & private sectors, and increasing population.

Pediatric Clinical Trials Market Study Design

The phase IV segment accounts for key share of the market

On the basis of phases, the pediatric clinical trials market share is segmented into phase IV, phase III, phase I, and phase II. The phase IV segment accounts for a key share of the market. Growth of the market is attributed to increasing number of small & medium pharmaceuticals industry and presence of major market players.

The phase III is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing healthcare expenditure, growing rate of approval of new pediatric drugs, and rising prevalence of cancer in the pediatric age group.

Pediatric Clinical Trials Market Phases

North America is estimated to hold major market share

Based on regions, the pediatric clinical trials market share is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of Asia Pacific is estimated to expand at a high CAGR during the forecast period due to factors such as increasing number of pediatric diabetes worldwide, institution focusing on development of therapeutic drugs, and increasing awareness among patents about trials.

The market of North America is estimated to hold major market share due to presence of major market players, increasing production capacity of pharmaceutical manufactures, and increasing research & development activities in pediatric clinical trials.

Pediatric Clinical Trials Market Region

Segments

The pediatric clinical trials market has been segmented on the basis of

Phases

  • Phase IV
  • Phase III
  • Phase I
  • Phase II

Study Designs

  • Observational Studies
  • Treatment Studies
  • Others

Therapeutic Area

  • Diabetes
  • Respiratory Diseases
  • Oncology
  • Infectious Diseases
  • Other Areas

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • The Emmes Company, LLC
  • Syneos Health Inc.
  • Pfizer, Inc.
  • IQVIA
  • GlaxoSmithKline plc
  • Charles River Laboratories International Inc.
  • ICON plc
  • Bristol-Myers Squibb Company
  • Covance Inc.
  • Novartis AG
  • Pharmaceutical Product Development, LLC
  • Paidion Research Inc.

Competitive Landscape

Key players competing in the pediatric clinical trials market include The Emmes Company, LLC; Syneos Health Inc.; Pfizer, Inc.; IQVIA; GlaxoSmithKline plc; Charles River Laboratories International Inc.; ICON plc; Bristol-Myers Squibb Company; Covance Inc.; Novartis AG; Pharmaceutical Product Development, LLC; and Paidion Research Inc.

Some of these players are using several market strategies such as collaborations, acquisitions, partnerships, merger, product launches, and capacity expansion to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.

Pediatric Clinical Trials Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pediatric Clinical Trials Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Pediatric Clinical Trials Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Pediatric Clinical Trials Market - Supply Chain
  4.5. Global Pediatric Clinical Trials Market Forecast
     4.5.1. Pediatric Clinical Trials Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Pediatric Clinical Trials Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Pediatric Clinical Trials Market Absolute $ Opportunity
5. Global Pediatric Clinical Trials Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Pediatric Clinical Trials Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Pediatric Clinical Trials Demand Share Forecast, 2019-2026
6. North America Pediatric Clinical Trials Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Pediatric Clinical Trials Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Pediatric Clinical Trials Demand Share Forecast, 2019-2026
7. Latin America Pediatric Clinical Trials Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Pediatric Clinical Trials Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Pediatric Clinical Trials Demand Share Forecast, 2019-2026
8. Europe Pediatric Clinical Trials Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Pediatric Clinical Trials Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Pediatric Clinical Trials Demand Share Forecast, 2019-2026
9. Asia Pacific Pediatric Clinical Trials Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Pediatric Clinical Trials Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Pediatric Clinical Trials Demand Share Forecast, 2019-2026
10. Middle East & Africa Pediatric Clinical Trials Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Pediatric Clinical Trials Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Pediatric Clinical Trials Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Pediatric Clinical Trials Market: Market Share Analysis
  11.2. Pediatric Clinical Trials Distributors and Customers
  11.3. Pediatric Clinical Trials Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. The Emmes Company, LLC
     11.4.2. Syneos Health Inc.
     11.4.3. Pfizer, Inc.
     11.4.4. IQVIA
     11.4.5. GlaxoSmithKline plc
     11.4.6. Charles River Laboratories International Inc.
     11.4.7. ICON plc

Methodology

Our Clients

General Mills
The John Holland Group
sinopec
Deloitte
FedEx Logistics
Nestle SA
Dassault Aviation
General Electric